Narayana HrudayalayaNSE:NH -0.09%93 EBITDA Margin % is 20.71% as of Mar. 2026, which is 27% above its 10-year median of 16.27. GuruFocus rates NSE:NH with a GF Score™ of 93/100 and a GF Value™ of ₹2,230.63 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Narayana Hrudayalaya ranks better than 77.25% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Narayana Hrudayalaya EBITDA Margin % Related Terms
Narayana Hrudayalaya EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Narayana Hrudayalaya's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NH vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Narayana Hrudayalaya's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Narayana Hrudayalaya EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Narayana Hrudayalaya's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Narayana Hrudayalaya's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Narayana Hrudayalaya (NSE:NH) has a EBITDA Margin % of 20.71% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Narayana Hrudayalaya and its competitors. This is 27% above median its historical median of 16.27. Over the past decade, Narayana Hrudayalaya's EBITDA Margin % has ranged from 7.92 to 25.08. According to the industry distribution chart, Narayana Hrudayalaya ranks #152 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 22.8%.
Is Narayana Hrudayalaya's EBITDA Margin % too high?
Narayana Hrudayalaya's current EBITDA Margin % of 20.71% is 27% above median its 10-year median of 16.27. Over the past 10 years, this metric has ranged from a low of 7.92 to a high of 25.08. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Narayana Hrudayalaya's value of 20.71% is 102.8% above this industry median. Based on the distribution chart, Narayana Hrudayalaya ranks #152 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Narayana Hrudayalaya has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Narayana Hrudayalaya's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Narayana Hrudayalaya ranks #152 out of 668 companies for EBITDA Margin %. This places Narayana Hrudayalaya in the top 23% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Narayana Hrudayalaya's value of 20.71% is 102.8% above this benchmark. Historically, Narayana Hrudayalaya's own EBITDA Margin % has ranged from 7.92 to 25.08 over the past decade. While the company's 10-year median is 16.27 vs. the industry median of 10.21, Narayana Hrudayalaya has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Narayana Hrudayalaya's current EBITDA Margin % of 20.71% is 102.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Narayana Hrudayalaya and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Narayana Hrudayalaya's current EBITDA Margin % is 20.71%, which is 27% above median its own 10-year median of 16.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Narayana Hrudayalaya stock overvalued right now?
Based on GuruFocus' analysis, Narayana Hrudayalaya (NSE:NH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,230.63, compared to a current price of ₹1,956.80 — trading 12.3% below its estimated fair value. The current EBITDA Margin % is 20.71%, which is 27% above median its 10-year median of 16.27 and 102.8% above the Healthcare Providers & Services industry median of 10.21. Narayana Hrudayalaya's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Narayana Hrudayalaya (NSE:NH), the current EBITDA Margin % is 20.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Narayana Hrudayalaya (NSE:NH) Overvalued in 2026?
Based on GuruFocus' analysis, Narayana Hrudayalaya stock appears to be undervalued.
The current stock price of ₹1,956.80 is trading 12.3% below its estimated GF Value™ of ₹2,230.63.
GuruFocus considers Narayana Hrudayalaya to be Modestly Undervalued.
Key valuation signals for NSE:NH:
EBITDA Margin %: 20.71% (27% above median its 10-year median of 16.27)
GF Value™: ₹2,230.63 vs. price of ₹1,956.80 (12.3% below fair value)
Industry Position: 102.8% above the Healthcare Providers & Services median (#152 of 668)
No single metric tells the full story. See the NSE:NH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Narayana Hrudayalaya Ltd is an India-based medical and healthcare service provider. The company is engaged in the business of running and operating hospitals, clinics, health centers, nursing homes, and other related activities. The Company's sole operating segment is Medical and Healthcare Related Services. It also provides surgery services such as Cardiac Surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, paediatrics, neonatology, gastroenterology, and oncology. It has business operations in India and the Rest of the world, of which the maximum revenue is generated from the business operations in India.
93GF Score
Get the complete analysis for NSE:NH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NH has been successfully added to your 
